Actively Recruiting
Swiss Multi-Center Clinical Register for Patients with Severe Asthma to Track Symptoms, Treatments, and Outcomes
Led by Prof. Dr. Jörg Leuppi · Updated on 2026-11-02
600
Participants Needed
10
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Severe asthma is a chronic lung condition involving persistent airway inflammation, causing difficulty breathing and varying symptoms. This research aims to establish a detailed clinical register for patients with severe asthma across multiple centers in Switzerland to better understand the diseases characteristics, treatment patterns, and outcomes. The study focuses on tracking changes in asthma symptom control over time and gathering data on the diseases natural history and healthcare impact. Participants with severe asthma receiving care at specialized centers will be enrolled in this observational study. The registry will collect routine clinical data including lung function tests, blood analyses, asthma control assessments, medication use, and quality of life questionnaires. Follow-up visits occur at four months after starting specific therapies and annually for up to 15 years to monitor disease progression and treatment effects. During the study, participants undergo regular evaluations such as lung function tests including FVC and FEV1, exhaled nitric oxide measurements, blood gas analysis, and blood counts. Researchers will track exacerbations, healthcare usage, and mortality alongside symptom control scores. This long-term observation aims to improve understanding of severe asthma management and outcomes while ensuring thorough documentation of complex therapies like antibody treatments. The total duration of participation may be up to 15 years with repeated yearly assessments.
CONDITIONS
Brief Title
Swiss Severe Asthma Register
Research Team
J
Jörg Leuppi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here